Indaptus Therapeutics
Price & Volume
Stats
See more52W Range | $1.65-$29.68 |
Market Cap | $3.5M |
Shares Short | 14,057 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$29.03 |
News
See moreYahoo Finance • last month
Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit
Yahoo Finance • 4 months ago
Indaptus Therapeutics Provides Clinical Update
Yahoo Finance • 4 months ago
Indaptus Therapeutics GAAP EPS of -$9.09
Yahoo Finance • 6 months ago
Indaptus Therapeutics raises $5.7 million through convertible notes
About
CEO | Mr. Jeffrey A. Meckler J.D. |
CFO | Mr. Nir Sassi |
Address | Three Columbus Circle, New York, NY, United States, 10019 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 7 |
